CN111704656A - Duck adenovirus I type Penton protein and preparation method and application thereof - Google Patents

Duck adenovirus I type Penton protein and preparation method and application thereof Download PDF

Info

Publication number
CN111704656A
CN111704656A CN202010630390.6A CN202010630390A CN111704656A CN 111704656 A CN111704656 A CN 111704656A CN 202010630390 A CN202010630390 A CN 202010630390A CN 111704656 A CN111704656 A CN 111704656A
Authority
CN
China
Prior art keywords
thr
ala
gly
cys
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010630390.6A
Other languages
Chinese (zh)
Inventor
王雪平
张孝俊
梁秀丽
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anyang Institute of Technology
Original Assignee
Anyang Institute of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anyang Institute of Technology filed Critical Anyang Institute of Technology
Priority to CN202010630390.6A priority Critical patent/CN111704656A/en
Publication of CN111704656A publication Critical patent/CN111704656A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/10011Adenoviridae
    • C12N2710/10111Atadenovirus, e.g. ovine adenovirus D
    • C12N2710/10122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01DNA viruses
    • G01N2333/075Adenoviridae
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00Immunoassays for the detection of microorganisms
    • G01N2469/20Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention belongs to the field of protein engineering, and particularly relates to duck adenovirus type I Penton protein and a preparation method and application thereof. The inventors analyze and find that the Penton protein is hydrophilic, has no transmembrane structural domain, has no advantage selection such as signal peptide prediction and the like to carry out full-length expression. The Penton target segment is obtained by artificial synthesis after sequence optimization, and the expression mode of the protein is cell-free protein expression. Compared with the traditional Penton protein antigen dominant epitope truncated expression, the accuracy of the artificially synthesized and expressed Penton recombinant protein is high, the neutralization of the protein is ensured, the trouble of high mutation rate is avoided, and the development of the antibody detection technology is facilitated. In addition, the expression system has unique advantages, including time savings and increased overall yield of soluble, full-length proteins. In addition, the expression system has low cost, large expression quantity and strong reaction property of Western Blot detection.

Description

Duck adenovirus I type Penton protein and preparation method and application thereof
Technical Field
The invention belongs to the field of protein engineering, and particularly relates to duck adenovirus type I Penton protein and a preparation method and application thereof.
Background
Duck adenovirus type I virus (Duck adenovirus type 1, DAV 1) is a type of adenovirus including Egg Drop Syndrome Virus (EDSV) or EDSV-like, and is a member of the genus Thoracivirus (Atadenvirus) of the family adenoviridae. The representative virus is Egg Drop Syndrome (EDSV), which causes viral infectious diseases that decrease the laying rate of laying hens or breeding hens. After the laying hens are infected with the EDS virus, the egg yield of a chicken group cannot reach a peak period or is greatly reduced, the egg yield can be reduced by 20-30%, the development of the laying hen industry is seriously influenced, huge economic loss is brought to vast farmers and breeding enterprises, and the harmfulness is very serious.
DAV1 has the distribution in the world at present, has brought serious economic loss for the poultry industry of many countries, and ELLSA has advantages such as simple and convenient, swift, sensitive, specific when detecting the antibody, obtains extensive application in the production field, but present kit mainly regards whole virus as the envelope antigen, and the process of purification virion is complicated, and has the risk of dispersing the poison, is not suitable for a series of difficult problems of popularization and application such as monitoring of a large amount of chicken crowd antibody levels and epidemiological investigation.
In view of the severity of the hazards of DAV1 to the poultry industry, serological diagnosis of poultry using reliable and rapid serodiagnostic techniques is the basis for effective prevention and control. Therefore, a kit for accurately diagnosing the DAV1 by a serological diagnosis method is established, and the kit has important significance for preventing and treating the disease.
Disclosure of Invention
The invention provides application of duck adenovirus type I Penton protein, which constructs recombinant plasmid of duck adenovirus type I Penton protein, then adds the plasmid into E.coli dialysis cell-free recombinant protein system and further establishes a kit by taking the purified protein as coating antigen.
The technical scheme of the invention is realized as follows:
a duck adenovirus type I protein, wherein the amino acid sequence of the Penton protein is shown as SEQ ID No. 1.
The preparation method of the duck adenovirus I type Penton protein comprises the following steps:
(1) synthesizing a Penton gene, and connecting the Penton gene between NdeI and BamHI of a pET-11a vector to obtain a recombinant plasmid pET-11 a-Penton;
(2) adding the recombinant plasmid pET-11a-Penton with correct sequencing in the step (1) as a template into an E.coli dialysis cell-free recombinant protein system, and standing for 16 hours at 25 ℃;
(3) and (3) collecting, centrifuging and collecting precipitates in the step (2), and performing affinity purification on the precipitates through a Ni column to finally obtain the duck adenovirus I type Penton protein.
The application of the Penton recombinant protein in preparing an indirect ELISA kit for detecting duck adenovirus type I antibody comprises an expression protein ELISA plate, negative control serum, positive control serum, an enzyme-labeled secondary antibody diluent, a buffer solution, a confining solution, a diluent, a washing solution, a developing solution and a stop solution.
The expression protein ELISA plate takes Penton recombinant protein as a coating antigen, each hole is coated with 0.4 mu g of the recombinant protein Penton, positive control is duck adenovirus I-resistant chicken serum, and negative control is SPF chicken serum.
The diluent or the washing solution is PBST containing 0.05 percent of Tween-20, and the stop solution is 2M H2SO4The solution is 100mL of TMB developing solution.
The invention has the following beneficial effects:
1. the inventors analyze and find that the Penton protein is hydrophilic, has no transmembrane structural domain, has no advantage selection such as signal peptide prediction and the like to carry out full-length expression. The Penton target segment is obtained by artificial synthesis after sequence optimization, and the expression mode of the protein is cell-free protein expression.
2. Compared with the traditional Penton protein antigen dominant epitope truncated expression, the accuracy of the artificially synthesized and expressed Penton recombinant protein is high, the neutralization of the protein is ensured, the trouble of high mutation rate is avoided, and the development of the antibody detection technology is facilitated. On the other hand, we have adopted a cell-free protein expression system that has unique advantages, including time savings and increased overall yield of soluble, full-length protein. In addition, the expression system has low cost, large expression quantity and strong reaction property of Western Blot detection. The indirect ELLSA method established based on the Penton protein as the coating antigen has good specificity. The detection result of clinical samples shows that the method can be used as a method for detecting the duck adenovirus type I antibody, and is favorable for popularization and application in most farmers at the basic level. The detection method of the invention also has the advantages of capability of simultaneously detecting a large number of samples and rapidness and convenience in detection.
Drawings
In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings used in the description of the embodiments or the prior art will be briefly described below, it is obvious that the drawings in the following description are only some embodiments of the present invention, and for those skilled in the art, other drawings can be obtained according to the drawings without creative efforts.
FIG. 1 is a diagram showing the accuracy of the restriction analysis and identification of the prokaryotic expression plasmid pET-11a-Penton in example 1 of the present invention.
FIG. 2 is a graph showing the result of IPTG-induced expression of the Penton protein, which is identified by SDS-PAGE analysis in example 1 of the present invention.
FIG. 3 is a graph showing the results of SDS-PAGE analysis to identify Ni column affinity purification induced expression in example 1 of the present invention.
FIG. 4 is a Western blot result chart according to example 1 of the present invention.
Detailed Description
The technical solutions of the present invention will be described clearly and completely with reference to the following embodiments of the present invention, and it should be understood that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be obtained by a person skilled in the art without inventive effort based on the embodiments of the present invention, are within the scope of the present invention.
Example 1
1. Amplification of a Penton protein sequence and construction of a prokaryotic expression plasmid pET-11 a-Penton:
the method comprises the steps of synthesizing a Penton protein gene by using a whole gene, wherein the amino acid sequence table of the Penton protein is SEQ.ID.No.1, the nucleotide sequence table of the recombinant Penton protein gene is SEQ.ID.No.2, inserting the recombinant Penton protein gene into a pET-11a expression vector through restriction enzyme sites NdeI and BamHI, respectively adding 3 mu L of the recombinant pET-11a-Penton plasmid, 0.25 mu L of endonuclease I, 0.25 mu L of endonuclease and 1.0 mu L of 10 xBuffer into a 25 mu L centrifugal tube, fully mixing the mixture, placing the mixture into a low-temperature connector at the temperature of 16 ℃ for carrying out a connection reaction for 30min to obtain a connection product, carrying out double enzyme digestion and sequencing on the connection product through restriction enzyme sites Nde I and BamHI to confirm the accuracy of a final expression vector, and obtaining the prokaryotic expression plasmid pET-11 a-Penton. FIG. 1 is a diagram showing the results of enzyme digestion identification of a prokaryotic expression plasmid pET-11a-Penton, in which M is 1Kb DNA Marker; lane 1 is pre-enzyme cut plasmid; lane 2 is the plasmid after digestion, and it can be seen from FIG. 1 that the Penton protein gene fragment matches the expected molecular weight, and sequencing shows that the construction of the Penton protein expression vector is successful.
2. Coli dialysis cell-free protein expression and purification
Recovering and massively culturing the bacterial strain containing the pET-11a-Penton plasmid, and performing PCR amplification on the target gene by using DNA primers at two sides of the gene sequence inserted into the pET-11a-Penton plasmid. Specifically, a forward primer (5'-GATCCCGCGAAATTA-3') upstream of the T7 promoter sequence and a reverse primer (5'-AAAAACCCCTCAAGA-3') downstream of the T7 terminator sequence were used. The DNA template was amplified using Z1 or Z2 DNA polymerase for PCR amplification. FIG. 2 is a graph showing the results of PCR amplification, in which M is 1Kb DNA Marker in FIG. 2; lanes 1 and 2 are PCR amplification products, the amplified gene fragments correspond to the expected molecular weights. Adding the PCR amplification product into an E.coli dialysis cell-free protein expression system, standing the translation reaction at 25 ℃ for 16 hours, and identifying the sample by SDS-PAGE. FIG. 3 is a graph showing the results, in which M is 10-180Kb Protein Marker; lane 1 is the target protein expression profile; lane 2 is a control expression profile; as can be seen, the Penton protein was successfully expressed.
3. Ni column affinity purification and result analysis of fusion protein
The inclusion body solution was loaded to Ni-IDA Binding-Buffer pre-equilibrated at a flow rate of 0.5 ml/min using a low pressure chromatography system
Ni-IDA-Sepharose CL-6B affinity chromatography column; flushing with Ni-IDA Binding-Buffer at a flow rate of 0.5 ml/min until the effluent OD280 value reaches the baseline; washing with Ni-IDA Washing-Buffer (20M Tris-HCl, 20M M imidazole, 0.15M NaCl, pH8.0) at a flow rate of 1ml/min until the effluent OD280 value reaches baseline; eluting the target protein with Ni-IDA Elution-Buffer (20M M Tris-HCl, 250 mM imidazole, 0.15M NaCl, pH8.0) at a flow rate of 1ml/min, and collecting the eluate; adding the collected protein solution into a dialysis bag, and dialyzing overnight with PBS (pH 7.4); 10% SDS-PAGE analysis showed that at a relative molecular mass of about 54 kDa, 1 specific Protein band was observed, which was consistent with the expected size, and the results are shown in FIG. 4, where M is 10-180Kb Protein Marker; lane 1 is the protein of interest;
4. immunoblot assay verification result chart
The result is shown in figure 4, the purified Penton protein is verified by immunoblotting (Western blot), and the purified antibody can perform specific reaction with duck adenovirus type I protein, which shows that the prepared primary antibody has better reactivity. In the figure, M is 10-180Kb Protein Marker, lane 1 is Penton recombinant Protein, and the result shows that a band is obvious at the expected size, which proves that the purified Penton Protein has good reactogenicity.
Example 2
The embodiment is an application of the pentan protein described in embodiment 1, the pentan protein is used for an indirect ELISA kit for detecting duck adenovirus type i antibodies, the indirect ELISA kit comprises an expression protein ELISA plate, negative control serum, positive control serum, an ELISA secondary antibody diluent, a buffer solution, a confining solution, a diluent, a washing solution, a developing solution and a stop solution, and the coated ELISA plate takes the pentan protein as a coating antigen.
1. Preparation of enzyme-labeled secondary antibody: rabbit anti-duck IgG (produced by Beijing Baiolai Boke technology, Inc.) was diluted 100-fold with HRP conjugate stabilizer/diluent I (produced by English, Huzhou, Inc.).
2. Preparing a coated enzyme-labeled secondary antibody diluent, a buffer solution, a confining solution, a sample diluent and a washing solution:
the enzyme-labeled secondary antibody diluent is 0.01M phosphate buffer saline solution b with the pH value of 7.2-7.4, and the mass fraction of chicken serum in the phosphate buffer saline solution b is 5%;
the coating buffer solution is 0.05M carbonate buffer solution with the pH value of 9.6, and the preparation method of the carbonate buffer solution comprises the following steps: taking Na2CO3、1.59g、NaHCO32.93g, adding 800mL of sterilized double distilled water for dissolving, adjusting the pH to 9.6, and adding the sterilized double distilled water to 1000m L;
the confining liquid is 0.01M phosphate buffer salt solution a with the pH value of 7.2-7.4, the mass fraction of chicken serum in the phosphate buffer salt solution a is 5%, and the mass fraction of casein is 0.25%;
the sample diluent is 0.01M phosphate buffer salt solution d with the pH value of 7.2-7.4, the mass fraction of the chicken serum albumin in the phosphate buffer salt solution d is 0.1%, and the mass fraction of the sucrose in the phosphate buffer salt solution d is 2%.
3. Preparing a color developing solution and a stop solution:
the color development liquid comprises a color development liquid A and a color development liquid B; the preparation method of the color developing liquid A comprises the following steps: dissolving 200mg of tetramethylbenzidine in 100m L absolute ethyl alcohol, and diluting the solution to 1000m L by double distilled water; the preparation method of the color developing solution B comprises the following steps: weighing 21g of citric acid and 28.2g of anhydrous sodium phosphate, adding 6.4m L of 0.75% urea hydrogen peroxide solution, metering the volume of double distilled water to 1000m L, and adjusting the pH value to 4.5-5.0; the stop solution is 2M H2SO4And (3) solution.
4. Determination of ELISA reaction conditions:
determination of optimal coating concentration optimal dilution factor of sample: respectively diluting the antigen (Penton protein) by a multiple ratio according to (1 mu g/mL, 2 mu g/mL, 4 mu g/mL, 8 mu g/mL, 16 mu g/mL, 32 mu g/mL and 64 mu g/mL) by adopting a matrix method, sequentially coating the antigen (Penton protein) in an enzyme label plate, repeating 4 holes for each gradient, coating the antigen in each hole at 4 ℃ by 100 mu L, diluting the negative control serum and the positive serum by sample diluent of 1: 25, 1: 50, 1: 100 and 1: 200 times respectively, performing indirect ELISA, finally determining the optimal antigen coating amount to be 4 mu g/mL and 100 mu L/hole according to a P/N value (positive sample OD value/negative sample OD value), and determining the optimal dilution of the sample to be 1: 50 The enzyme-labeled secondary antibody action time, the substrate color development time and the like are optimized one by one, and finally the optimal reaction conditions of the indirect ELISA of the duck adenovirus type I antibody are determined as follows: the optimal amount of coating antigen is 5 mug/mL, 100 mug/hole, coating for 16h at 4 ℃, and sealing for 2h at 37 ℃; diluting the serum to be detected by 50 times, and incubating for 0.5h at 37 ℃; enzyme-labeled secondary antibody dilution is 1: 10000, 37 ℃ for 0.5 h; the substrate color development condition is that TMB (3,3',5,5' -tetramethyl benzidine) substrate is developed for 10min at room temperature in dark.
5. Determination of negative and positive cut-off values for indirect ELISA
Under the optimal conditions of indirect ELISA, 46 negative serum samples from non-infected duck adenovirus type I are used to determine the Cut-Off value (Cut-Off) of the indirect ELISA, the calculation method is to add three times of standard deviation (S.D.) to the average value of 46 negative serum OD450, and the test sample OD450nm is determined to be positive when the value is greater than or equal to the Cut-Off value, otherwise, the test sample is determined to be negative.
The cutoff value of the indirect ELISA method established by pentan was calculated to be 0.425 according to the cutoff calculation formula (Cut-Off ═ negative sample OD450 mean value +3 × s.d.). According to the method, when a duck serum sample is detected by using an indirect ELISA method established by Penton, the duck adenovirus type I antibody is determined to be positive when the OD450 value is more than or equal to 0.534; on the contrary, when the OD450 value is less than 0.534, the duck adenovirus type I antibody is determined to be negative.
6. Intra-and inter-batch reproducibility of indirect ELISA detection methods
9 duck adenovirus type I positive sera were selected to determine the intra-and inter-batch reproducibility of the indirect ELISA. Respectively detecting 9 positive serum samples in the ELISA plates coated in the same batch and 5 different batches, making 3 repeated holes on the same ELISA plate for each sample, determining OD450 values, respectively calculating the OD450 average value and Standard Deviation (SD) of each serum sample, and determining the in-batch and inter-batch repeatability of the established indirect ELISA method by calculating the coefficient of variation. The result shows that the intra-batch repeated variation coefficient of the indirect ELISA method established based on Penton is between 1% and 4.57%, the inter-batch repeated variation coefficient is between 1.58% and 5.25%, and all the variation coefficients are within 10%, which indicates that the indirect ELISA method established based on Penton has good repeatability and reliable result.
7. Specificity analysis of Indirect ELISA method
The OD values of positive sera of duck adenovirus type I (DAdV-1), Avian Influenza Virus (AIV), newcastle disease virus, avian adenovirus type 4 (FAdV-4), avian adenovirus type 8 (FAdV-8) and avian Reovirus (REO) chickens are simultaneously determined by the ELISA method established above, and the result shows that only the detection result of the serum of the duck adenovirus type 1 is positive, and the detection results of the positive sera of other pathogens are negative.
8. The duck adenovirus type I indirect ELISA detection kit comprises:
(1) the coated plate is coated with an enzyme label plate (coated with Penton protein) 6;
(2) negative control serum 3m L;
(3) positive control serum 3m L;
(4) enzyme-labeled secondary antibody 0.8m L;
(5) enzyme-labeled secondary antibody diluent 80m L;
(6) sample diluent 150m L;
(7) color developing liquid a 50m L;
(8) color developing solution B50 m L;
(9) stop solution 50m L;
(10) concentrated washings (20 × washings) 150m L;
(11) 8 cover plate films;
(12) 8 serum dilution plates;
(13) 1 part of a specification.
9. The duck adenovirus type I antibody indirect ELISA kit operation instruction:
(1) coating: taking the purified Penton protein as a coating antigen, diluting the Penton protein with a carbonate buffer solution, adding the diluted Penton protein into an ELISA plastic hole plate with 96 holes, coating each hole with 100 mu L of the solution at 4 ℃ overnight; discarding redundant antigens in the coated wells, adding 200 mu L of PBST into each well, washing for 4 times, and then patting the plate to be dry;
(2) and (3) sealing: adding 200 mu L of sealing liquid into each hole, sealing for 2h at 37 ℃; discarding the confining liquid, washing with PBST for 4 times, and drying after washing;
(3) adding serum to be detected: adding 100 mu L of chicken serum diluted by PBS buffer solution into each hole, and incubating for 1h at 37 ℃; discarding redundant serum in the incubated hole, washing with PBST for 4 times, and drying after washing;
(4) adding a secondary antibody: mu.L of goat anti-chicken IgG enzyme-labeled secondary antibody diluted with PBS buffer was added to each well and incubated at 37 ℃ for 1 h. Then, discarding redundant enzyme-labeled secondary antibodies in the incubated holes, washing for 4 times by using PBST, and then patting dry after washing;
(5) color development: adding 100 μ L of TMB color developing agent into each well, and developing at 37 deg.C in dark for 10 min; and (4) terminating: blue-green color appears in duck type 1 adenovirus positive serum sample hole, and 0.5M HSO is added immediately4Terminating the reaction;
(6) and (5) judging a result: after the reaction was terminated, the reaction mixture was placed in a microplate reader, and the OD value of each sample was read at 450 nm. Immediately reading on a microplate reader at 450nm, and determining the titer of the sample according to the dilution corresponding to the well with the OD value being greater than 2.1 times of the set negative control OD value.
Example 3
98 parts of chicken serum samples which are clinically checked are detected by using the duck adenovirus type I antibody indirect ELISA method. The chicken serum detects 25 parts of duck type 1 adenovirus positive serum, the positive rate is 25%, which indicates that the duck type 1 adenovirus has higher infection rate in the chicken group to be inspected, and the indirect ELISA method established by taking the purified Penton protein as the coating antigen has the characteristics of good specificity and high sensitivity.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents, improvements and the like that fall within the spirit and principle of the present invention are intended to be included therein.
<110> Anyang industry and college
<120> duck adenovirus type I Penton protein and preparation method and application thereof
<141>2020-07-03
<160>2
<170>SIPOSequenceListing 1.0
<210>1
<211>452
<212>PRT
<213>duck adenovirus
<400>1
Met Glu Ser Phe Val Pro Pro Pro Arg Val Phe Ala Pro Thr Glu Gly
1 5 10 15
Arg Asn Ser Ile Thr Tyr Asn Ala Phe Ala Pro Leu Gln Asp Thr Thr
20 25 30
Asn Leu Tyr Tyr Ile Asp Asn Lys Thr Ser Asp Ile Glu Ala Leu Asn
35 40 45
Leu Thr Asn Asp His Ser Asp Tyr Phe Thr Asn Ile Ile Gln Asn Ala
50 55 60
Asp Val Ser Pro Thr Glu Ser Ala Thr Gln Asp Ile Lys Leu Asp Glu
65 70 75 80
Arg Ser Arg Trp Ser Gly Asn Leu Val Thr Leu Leu Lys Thr Asn Cys
85 90 95
Pro Asn Val Thr Glu Tyr Asn Asn Ser Asn Lys Val Arg Val Arg Leu
100 105 110
Met Thr Asp Lys Thr Asp Pro Gln Asn Pro Val Tyr Glu Trp Val Glu
115 120 125
Ile Glu Ile Pro Glu Gly Asn Tyr Thr Gly Asn Glu Ile Ile Asp Leu
130 135 140
Leu Asn Asn Ala Val Leu Glu His Tyr Leu Lys Val Gly Arg Gln Asn
145 150 155160
Asn Val Glu Val Ser Asp Ile Gly Val Lys Phe Asp Thr Arg Met Phe
165 170 175
Gly Leu Gly Gln Asp Pro Val Thr Ser Leu Ile Val Pro Gly Arg Tyr
180 185 190
Thr Tyr Lys Ala Phe His Pro Asp Ile Val Leu Leu Pro Asn Cys Gly
195 200 205
Val Asp Phe Thr Phe Ser Arg Leu Asn Asn Ile Leu Gly Ile Arg Lys
210 215 220
Arg Asn Pro Tyr Met Lys Gly Phe Ile Ile Met Tyr Asp Asp Leu Glu
225 230 235 240
Gln Gly Asn Ile Pro Ala Leu Leu Asp Thr Thr Lys Tyr Pro Ala Glu
245 250 255
Val Leu Pro Val Leu Ala Asp Ala Asp Asn Val Ser Tyr Arg Val Gln
260 265 270
Gln Ile Ser Thr Asp Pro Pro Ala Trp Gln Thr Glu Tyr Arg Ser Trp
275 280 285
Ala Leu Ala Tyr His Asn Lys Gly Pro Ile Arg Thr Thr Thr Leu Leu
290 295 300
Thr Val Pro Asp Ile Thr Gly Gly Leu Gly Gln Leu Tyr Trp Ser Ile
305 310 315 320
Pro Asp Ser Phe Lys Ala Pro Ile Thr Phe Thr Ser Asn Thr Ser Asn
325 330 335
Thr Glu Thr Leu Pro Val Val Ala Met Gln Leu Phe Pro Leu Gln Gln
340 345 350
Arg Ile Val Tyr Asn Ala Ser Ala Val Tyr Ser Gln Leu Val Glu Gln
355 360 365
Met Thr Asn Asn Thr Lys Val Phe Asn Arg Phe Pro Asn Asn Glu Ile
370 375 380
Leu Met Gln Pro Pro Tyr Gly Thr Leu Thr Trp Ile Ser Glu Asn Val
385 390 395 400
Pro Ser Val Ala Asp His Gly Gln Gln Pro Leu Lys Asn Ser Leu Pro
405 410 415
Gly Val Gln Arg Ile Thr Leu Thr Asp Asp Arg Arg Arg Thr Cys Pro
420 425 430
Tyr Ile Tyr Lys Ser Leu Ala Arg Val Ser Pro Arg Val Ile Ser Ser
435 440 445
Ala Thr Leu Gln
450
<210>2
<211>1359
<212>PRT
<213>duck adenovirus
<400>2
Ala Thr Gly Gly Ala Gly Thr Cys Thr Thr Thr Thr Gly Thr Gly Cys
1 5 10 15
Cys Gly Cys Cys Gly Cys Cys Thr Cys Gly Thr Gly Thr Gly Thr Thr
20 25 30
Thr Gly Cys Thr Cys Cys Gly Ala Cys Gly Gly Ala Gly Gly Gly Ala
35 40 45
Cys Gly Ala Ala Ala Thr Ala Gly Thr Ala Thr Thr Ala Cys Cys Thr
50 55 60
Ala Cys Ala Ala Thr Gly Cys Cys Thr Thr Thr Gly Cys Thr Cys Cys
65 70 75 80
Thr Cys Thr Ala Cys Ala Ala Gly Ala Cys Ala Cys Ala Ala Cys Gly
85 90 95
Ala Ala Cys Cys Thr Gly Thr Ala Thr Thr Ala Cys Ala Thr Ala Gly
100 105 110
Ala Cys Ala Ala Cys Ala Ala Ala Ala Cys Ala Thr Cys Ala Gly Ala
115 120 125
Thr Ala Thr Thr Gly Ala Gly Gly Cys Cys Cys Thr Ala Ala Ala Cys
130 135 140
Cys Thr Thr Ala Cys Ala Ala Ala Thr Gly Ala Thr Cys Ala Cys Ala
145 150 155 160
Gly Thr Gly Ala Thr Thr Ala Cys Thr Thr Thr Ala Cys Ala Ala Ala
165 170 175
Thr Ala Thr Cys Ala Thr Ala Cys Ala Ala Ala Ala Thr Gly Cys Cys
180 185 190
Gly Ala Thr Gly Thr Gly Thr Cys Thr Cys Cys Gly Ala Cys Ala Gly
195 200 205
Ala Ala Thr Cys Gly Gly Cys Ala Ala Cys Thr Cys Ala Ala Gly Ala
210 215 220
Cys Ala Thr Cys Ala Ala Ala Thr Thr Ala Gly Ala Thr Gly Ala Gly
225 230 235 240
Cys Gly Gly Thr Cys Thr Ala Gly Gly Thr Gly Gly Thr Cys Ala Gly
245 250 255
Gly Ala Ala Ala Thr Thr Thr Gly Gly Thr Thr Ala Cys Thr Thr Thr
260 265 270
Gly Thr Thr Ala Ala Ala Ala Ala Cys Ala Ala Ala Thr Thr Gly Cys
275 280 285
Cys Cys Thr Ala Ala Thr Gly Thr Thr Ala Cys Thr Gly Ala Ala Thr
290 295 300
Ala Cys Ala Ala ThrAla Ala Thr Ala Gly Thr Ala Ala Thr Ala Ala
305 310 315 320
Gly Gly Thr Ala Cys Gly Cys Gly Thr Thr Cys Gly Cys Cys Thr Ala
325 330 335
Ala Thr Gly Ala Cys Thr Gly Ala Thr Ala Ala Gly Ala Cys Thr Gly
340 345 350
Ala Thr Cys Cys Thr Cys Ala Gly Ala Ala Thr Cys Cys Thr Gly Thr
355 360 365
Thr Thr Ala Thr Gly Ala Ala Thr Gly Gly Gly Thr Ala Gly Ala Ala
370 375 380
Ala Thr Thr Gly Ala Ala Ala Thr Ala Cys Cys Thr Gly Ala Gly Gly
385 390 395 400
Gly Thr Ala Ala Cys Thr Ala Thr Ala Cys Thr Gly Gly Cys Ala Ala
405 410 415
Thr Gly Ala Ala Ala Thr Thr Ala Thr Thr Gly Ala Thr Thr Thr Gly
420 425 430
Thr Thr Ala Ala Ala Thr Ala Ala Thr Gly Cys Thr Gly Thr Gly Cys
435 440 445
Thr Gly Gly Ala Gly Cys Ala Cys Thr Ala Thr Thr Thr Gly Ala Ala
450 455 460
Ala Gly Thr Thr Gly Gly Ala Ala Gly Gly Cys Ala Gly Ala Ala Thr
465 470 475 480
Ala Ala Cys Gly Thr Thr Gly Ala Gly Gly Thr Gly Thr Cys Thr Gly
485 490 495
Ala Thr Ala Thr Thr Gly Gly Ala Gly Thr Gly Ala Ala Ala Thr Thr
500 505 510
Thr Gly Ala Thr Ala Cys Thr Ala Gly Ala Ala Thr Gly Thr Thr Thr
515 520 525
Gly Gly Gly Thr Thr Gly Gly Gly Gly Cys Ala Ala Gly Ala Thr Cys
530 535 540
Cys Thr Gly Thr Ala Ala Cys Thr Thr Cys Thr Thr Thr Gly Ala Thr
545 550 555 560
Thr Gly Thr Gly Cys Cys Gly Gly Gly Thr Cys Gly Gly Thr Ala Thr
565 570 575
Ala Cys Thr Thr Ala Thr Ala Ala Ala Gly Cys Gly Thr Thr Thr Cys
580 585 590
Ala Thr Cys Cys Ala Gly Ala Thr Ala Thr Thr Gly Thr Ala Cys Thr
595 600 605
Thr Thr Thr Gly Cys Cys Cys Ala Ala Thr Thr Gly Cys Gly Gly Thr
610 615 620
Gly Thr Ala Gly Ala Thr Thr Thr Thr Ala Cys Cys Thr Thr Thr Thr
625 630 635 640
Cys Ala Cys Gly Gly Thr Thr Ala Ala Ala Cys Ala Ala Thr Ala Thr
645 650 655
Thr Cys Thr Thr Gly Gly Cys Ala Thr Thr Cys Gly Gly Ala Ala Gly
660 665 670
Cys Gly Thr Ala Ala Thr Cys Cys Thr Thr Ala Cys Ala Thr Gly Ala
675 680 685
Ala Ala Gly Gly Thr Thr Thr Thr Ala Thr Ala Ala Thr Thr Ala Thr
690 695 700
Gly Thr Ala Thr Gly Ala Thr Gly Ala Thr Thr Thr Ala Gly Ala Ala
705 710 715 720
Cys Ala Ala Gly Gly Cys Ala Ala Thr Ala Thr Thr Cys Cys Ala Gly
725 730 735
Cys Ala Cys Thr Gly Thr Thr Ala Gly Ala Thr Ala Cys Ala Ala Cys
740 745 750
Gly Ala Ala Ala Thr Ala Thr Cys Cys Gly Gly Cys Ala Gly Ala Gly
755 760 765
Gly Thr Ala Thr Thr Ala Cys Cys Thr Gly Thr Thr Cys Thr Gly Gly
770 775780
Cys Ala Gly Ala Thr Gly Cys Thr Gly Ala Thr Ala Ala Thr Gly Thr
785 790 795 800
Cys Thr Cys Ala Thr Ala Thr Ala Gly Ala Gly Thr Gly Cys Ala Ala
805 810 815
Cys Ala Ala Ala Thr Ala Thr Cys Thr Ala Cys Thr Gly Ala Thr Cys
820 825 830
Cys Cys Cys Cys Gly Gly Cys Thr Thr Gly Gly Cys Ala Gly Ala Cys
835 840 845
Thr Gly Ala Ala Thr Ala Thr Cys Gly Gly Thr Cys Ala Thr Gly Gly
850 855 860
Gly Cys Thr Cys Thr Thr Gly Cys Thr Thr Ala Thr Cys Ala Thr Ala
865 870 875 880
Ala Thr Ala Ala Gly Gly Gly Thr Cys Cys Thr Ala Thr Ala Cys Gly
885 890 895
Cys Ala Cys Gly Ala Cys Thr Ala Cys Thr Cys Thr Thr Cys Thr Gly
900 905 910
Ala Cys Ala Gly Thr Thr Cys Cys Thr Gly Ala Thr Ala Thr Thr Ala
915 920 925
Cys Thr Gly Gly Thr Gly Gly Ala Thr Thr Gly Gly Gly Ala Cys Ala
930935 940
Gly Cys Thr Ala Thr Ala Thr Thr Gly Gly Thr Cys Ala Ala Thr Thr
945 950 955 960
Cys Cys Ala Gly Ala Thr Thr Cys Thr Thr Thr Thr Ala Ala Ala Gly
965 970 975
Cys Thr Cys Cys Thr Ala Thr Thr Ala Cys Thr Thr Thr Thr Ala Cys
980 985 990
Ala Ala Gly Thr Ala Ala Thr Ala Cys Gly Thr Cys Cys Ala Ala Thr
995 1000 1005
Ala Cys Ala Gly Ala Ala Ala Cys Ala Cys Thr Gly Cys Cys Thr Gly
1010 1015 1020
Thr Cys Gly Thr Thr Gly Cys Cys Ala Thr Gly Cys Ala Gly Thr Thr
1025 1030 1035 1040
Gly Thr Thr Thr Cys Cys Ala Thr Thr Ala Cys Ala Ala Cys Ala Ala
1045 1050 1055
Cys Gly Thr Ala Thr Thr Gly Thr Ala Thr Ala Cys Ala Ala Thr Gly
1060 1065 1070
Cys Gly Thr Cys Thr Gly Cys Ala Gly Thr Ala Thr Ala Thr Thr Cys
1075 1080 1085
Thr Cys Ala Gly Thr Thr Gly Gly Thr Gly Gly Ala Gly CysAla Gly
1090 1095 1100
Ala Thr Gly Ala Cys Cys Ala Ala Thr Ala Ala Cys Ala Cys Cys Ala
1105 1110 1115 1120
Ala Ala Gly Thr Ala Thr Thr Thr Ala Ala Thr Ala Gly Ala Thr Thr
1125 1130 1135
Thr Cys Cys Ala Ala Ala Cys Ala Ala Thr Gly Ala Gly Ala Thr Thr
1140 1145 1150
Cys Thr Thr Ala Thr Gly Cys Ala Gly Cys Cys Ala Cys Cys Gly Thr
1155 1160 1165
Ala Cys Gly Gly Gly Ala Cys Cys Cys Thr Thr Ala Cys Ala Thr Gly
1170 1175 1180
Gly Ala Thr Thr Ala Gly Cys Gly Ala Ala Ala Ala Thr Gly Thr Cys
1185 1190 1195 1200
Cys Cys Thr Thr Cys Thr Gly Thr Thr Gly Cys Ala Gly Ala Thr Cys
1205 1210 1215
Ala Cys Gly Gly Cys Cys Ala Gly Cys Ala Gly Cys Cys Gly Thr Thr
1220 1225 1230
Gly Ala Ala Ala Ala Ala Cys Ala Gly Cys Cys Thr Gly Cys Cys Gly
1235 1240 1245
Gly Gly Thr Gly Thr Thr Cys Ala Ala Ala Gly Ala Ala Thr Ala Ala
1250 1255 1260
Cys Thr Cys Thr Gly Ala Cys Cys Gly Ala Cys Gly Ala Thr Ala Gly
1265 1270 1275 1280
Gly Cys Gly Gly Cys Gly Cys Ala Cys Thr Thr Gly Cys Cys Cys Gly
1285 1290 1295
Thr Ala Cys Ala Thr Cys Thr Ala Cys Ala Ala Ala Thr Cys Thr Thr
1300 1305 1310
Thr Gly Gly Cys Cys Cys Gly Cys Gly Thr Ala Thr Cys Thr Cys Cys
1315 1320 1325
Thr Cys Gly Gly Gly Thr Gly Ala Thr Thr Thr Cys Thr Ala Gly Cys
1330 1335 1340
Gly Cys Thr Ala Cys Thr Thr Thr Gly Cys Ala Ala Thr Ala Ala
1345 1350 1355

Claims (5)

1. Duck adenovirus type I Penton protein, its characterized in that: the amino acid sequence of the recombinant protein Penton is shown as SEQID No. 1.
2. The method for preparing duck adenovirus type I Penton protein according to claim 1, characterized in that the method comprises the following steps:
(1) synthesizing a Penton gene, and connecting the Penton gene between NdeI and BamHI of a pET-11a vector to obtain a recombinant plasmid pET-11 a-Penton;
(2) adding the recombinant plasmid pET-11a-Penton with correct sequencing in the step (1) as a template into an E.coli dialysis cell-free recombinant protein system, and standing for 16 hours at 25 ℃;
(3) and (3) collecting, centrifuging and collecting precipitates in the step (2), and performing affinity purification on the precipitates through a Ni column to finally obtain the duck adenovirus I type Penton protein.
3. The use of the pentan protein of claim 2 in the preparation of an indirect ELISA kit for detecting duck adenovirus type I antibodies, wherein the kit comprises: the indirect ELISA kit comprises an expression protein ELISA plate, negative control serum, positive control serum, an enzyme-labeled secondary antibody diluent, a washing solution, a developing solution and a stop solution.
4. Use according to claim 3, characterized in that: the expression protein ELISA plate takes Penton as a coating antigen, each hole is coated with 0.5 mu g of the Penton protein, positive control is duck adenovirus I-resistant chicken serum, and negative control is SPF chicken serum.
5. Use according to claim 4, characterized in that: the diluent or the washing solution is PBST containing 0.05 percent of Tween-20, and the stop solution is 2M H2SO4The solution is 100mL of TMB developing solution.
CN202010630390.6A 2020-07-03 2020-07-03 Duck adenovirus I type Penton protein and preparation method and application thereof Pending CN111704656A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010630390.6A CN111704656A (en) 2020-07-03 2020-07-03 Duck adenovirus I type Penton protein and preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010630390.6A CN111704656A (en) 2020-07-03 2020-07-03 Duck adenovirus I type Penton protein and preparation method and application thereof

Publications (1)

Publication Number Publication Date
CN111704656A true CN111704656A (en) 2020-09-25

Family

ID=72546425

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010630390.6A Pending CN111704656A (en) 2020-07-03 2020-07-03 Duck adenovirus I type Penton protein and preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN111704656A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112725533B (en) * 2021-01-21 2022-05-17 福建省农业科学院畜牧兽医研究所 Primer group for real-time fluorescent quantitative PCR identification of duck type 1 adenovirus and duck type 4 adenovirus

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107365364A (en) * 2016-05-12 2017-11-21 兰州雅华生物技术有限公司 A kind of quick detection kit of Adenovirus Antigen preparation method and the detection adenovirus antibody prepared using the antigen
CN108653725A (en) * 2017-04-01 2018-10-16 普莱柯生物工程股份有限公司 It is a kind of for prevent fowl egg drop syndrome vaccine composition, and its preparation method and application
CN108728419A (en) * 2018-06-07 2018-11-02 扬州大学 Express aviadenovirus penton Protein reconstitutions newcastle disease vaccine Candidate Strain rAI4-penton and construction method
CN109750036A (en) * 2017-11-03 2019-05-14 普莱柯生物工程股份有限公司 Nucleotide sequence, the method and application that protein expression efficiency is improved using it
CN110575538A (en) * 2018-06-11 2019-12-17 普莱柯生物工程股份有限公司 Avian influenza virus-like particle vaccine, and preparation method and application thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107365364A (en) * 2016-05-12 2017-11-21 兰州雅华生物技术有限公司 A kind of quick detection kit of Adenovirus Antigen preparation method and the detection adenovirus antibody prepared using the antigen
CN108653725A (en) * 2017-04-01 2018-10-16 普莱柯生物工程股份有限公司 It is a kind of for prevent fowl egg drop syndrome vaccine composition, and its preparation method and application
CN109750036A (en) * 2017-11-03 2019-05-14 普莱柯生物工程股份有限公司 Nucleotide sequence, the method and application that protein expression efficiency is improved using it
CN108728419A (en) * 2018-06-07 2018-11-02 扬州大学 Express aviadenovirus penton Protein reconstitutions newcastle disease vaccine Candidate Strain rAI4-penton and construction method
CN110575538A (en) * 2018-06-11 2019-12-17 普莱柯生物工程股份有限公司 Avian influenza virus-like particle vaccine, and preparation method and application thereof

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
DUARTE等: "Faecal Virome Analysis of Wild Animals from Brazil", 《VIRUSES》 *
HESS等: "NP_044706.1", 《NCBI/GENBANK》 *
HESS等: "NP_044710.1", 《NCBI/GENBANK》 *
HESS等: "The complete nucleotide sequence of the egg drop syndrome virus: an intermediate between mastadenoviruses and aviadenoviruses", 《VIROLOGY》 *
康文彪等: "《基础兽医实验室建设与管理》", 30 June 2016, 甘肃科学技术出版社 *
李卫芳等: "《生物化学与分子生物学实验》", 31 January 2012, 中国科学技术大学出版社 *
汪世龙: "《蛋白质化学》", 31 August 2012, 同济大学出版社 *
程安春: "《养鸭与鸭病防治 第3版》", 30 September 2012, 中国农业大学出版社 *
苏敬良等: "《鸭病学》", 31 December 2016, 中国农业大学出版社 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112725533B (en) * 2021-01-21 2022-05-17 福建省农业科学院畜牧兽医研究所 Primer group for real-time fluorescent quantitative PCR identification of duck type 1 adenovirus and duck type 4 adenovirus

Similar Documents

Publication Publication Date Title
Sheng et al. Nanobody-horseradish peroxidase fusion protein as an ultrasensitive probe to detect antibodies against Newcastle disease virus in the immunoassay
CN110221065B (en) Poultry bursa of sliding mycoplasma indirect ELISA detection kit
CN111751553B (en) Peste des petits ruminants virus H protein antibody iELISA detection method and application
CN111381032A (en) Indirect ELISA detection method for detecting porcine epidemic diarrhea virus antibody and kit thereof
CN103059109B (en) Mycoplasma pneumonia antigen, preparation method and immunodetection kit
CN110873792A (en) African swine fever virus antibody detection kit
CN114736290B (en) Nanometer antibody capable of recognizing porcine pseudorabies virus with high accuracy and sensitivity, preparation method and application
CN113943354B (en) Recombinant feline herpesvirus gB protein antigen and application thereof in antibody diagnosis and vaccine preparation
CN109239341B (en) Indirect ELISA kit for detecting bovine haemolytic mannheimia antibody and application thereof
CN110483625A (en) A kind of Mycoplasma bovis imagination albumen MbovP732 and its application
CN111704656A (en) Duck adenovirus I type Penton protein and preparation method and application thereof
CN111621506B (en) Mycoplasma bovis secretory protein Mbovp0145 and application thereof
CN108680741B (en) Infectious bronchitis virus 5b ELISA antibody detection kit and application thereof
CN109283334B (en) Recombinant antigen composition for detecting herpes simplex virus II type IgG antibody and kit thereof
Nuyttens et al. Identification, expression and serological evaluation of the recombinant ATP synthase beta subunit of Mycoplasma pneumoniae
CN114933639B (en) African swine fever virus p72N epitope protein and preparation method and application thereof
CN110794134B (en) Application of Eimeria siei SAG4 protein
CN110988340B (en) Application of Eimeria siei SAG8 protein
CN109655610B (en) Indirect ELISA (enzyme-linked immunosorbent assay) detection kit for pseudorabies virus
CN111393510B (en) African swine fever virus recombinant antigen and application thereof
CN108693357B (en) Indirect ELISA (enzyme-linked immunosorbent assay) detection kit for detecting novel chicken reovirus antibody and application
CN111537736A (en) Indirect ELISA (enzyme-linked immunosorbent assay) detection kit and detection method for mycoplasma gallisepticum antibody
CN111732636A (en) Duck adenovirus type 1 recombinant protein Hexon and preparation method and application thereof
CN115785286B (en) Fusion protein of porcine reproductive and respiratory syndrome virus and application thereof
CN114106158B (en) Nanometer antibody targeting porcine pseudorabies virus gD protein, preparation method and application

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20200925